Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

FTC probing impact of physician practice consolidation during busy M&A period for radiology

The agency has ordered six major commercial insurers to share 2015-2020 data to better understand how these trends alter competition.

Thumbnail

Hospital suspends mammography services that posed ‘serious risk to human health’

The U.S. Food & Drug Administration first revealed the imaging issue in a recently shared update.

Thumbnail

Time awake and hours slept significantly impact less experienced radiologists’ performance

That's according to a new investigation of sleep and how it affects physicians' ability to read images, published in JACR

Thumbnail

Stephen Hahn resigns as FDA commissioner, says he was ‘disgusted’ by Capitol Hill riots

A board-certified radiation oncologist, Hahn first joined the federal agency in December 2019, just before the COVID-19 storm hit. 

Las Vegas

Radiology Business Management Association postpones annual meeting due to COVID-19

RBMA certainly isn't alone, as numerous imaging conferences have been retooled or shelved over the past year. 

More evidence hospitals grudgingly complying on price transparency for ‘shoppable services’

Another quick field check has found the federal rule requiring hospitals to show their prices for shoppable services meeting with only spotty compliance since it went into effect Jan. 1.

Thumbnail

Large health system paying record $7.75M for carelessness with pain pills

Fifteen-hospital McLaren Health Care has agreed to pay $7.75 million for illegally distributing prescription painkillers. 

Thumbnail

New generic drug company named after Mark Cuban first founded by a part-time radiologist

Alex Oshmyansky, MD, PhD, who works weekends as a staff radiologist, first founded the Dallas-based startup in 2018.